Gastrointestinal Cancer News

Novartis has reached an agreement with biopharmaceutical company TScan Therapeutics to develop new autologous T-cell receptor therapies for the treatment of solid tumors.

Cetuximab plus chemotherapy resulted in shorter PFS and OS compared with chemotherapy alone among patients with resectable KRAS exon 2 wild-type colorectal liver metastases, according to results of the randomized phase 3 New EPOC study published in Lancet Oncology.

The FDA approved encorafenib in combination with cetuximab for adults with previously treated BRAF V600E-mutant metastatic colorectal cancer.

A nonoperative watch-and-wait strategy appeared comparable to upfront surgery in survival outcomes and could confer a quality-of-life benefit and significant cost savings for certain patients with rectal cancer, according to results of a modeling study published in Journal of the National Cancer Institute.

The FDA granted priority review to pembrolizumab for treatment of adults and children with unresectable or metastatic solid tumors that have high tissue tumor mutational burden.

A novel blood test accurately detected more than 50 types of cancer with a specificity of 99.3%, according to results of the prospective Circulating Cell-free Genome Atlas study published in Annals of Oncology.

Colorectal Cancer Awareness Month is observed in March.

Individuals aged 25 years and younger with colon cancer appeared to be at higher risk for relapse and death than their older adults, according to data published in Journal of the American College of Surgeons.

Reidunn Edelmann, PhD, has always been interested in blood vessels.

Risk for infection with SARS-CoV-2 — the novel coronavirus that causes COVID-19 — appeared more than twice as high among individuals with cancer than the general population, according to an analysis of data from a tertiary care hospital in Wuhan, China.